Hyun Hoon Chung

ORCID: 0000-0002-5158-7492
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Cervical Cancer and HPV Research
  • Endometriosis Research and Treatment
  • Uterine Myomas and Treatments
  • Radiomics and Machine Learning in Medical Imaging
  • Intraperitoneal and Appendiceal Malignancies
  • Colorectal and Anal Carcinomas
  • PARP inhibition in cancer therapy
  • MRI in cancer diagnosis
  • Cancer Risks and Factors
  • Gastric Cancer Management and Outcomes
  • Cancer, Lipids, and Metabolism
  • BRCA gene mutations in cancer
  • Cancer Genomics and Diagnostics
  • Renal cell carcinoma treatment
  • Ferroptosis and cancer prognosis
  • Nutrition and Health in Aging
  • Cancer-related molecular mechanisms research
  • RNA modifications and cancer
  • Ultrasound and Hyperthermia Applications
  • Cancer, Hypoxia, and Metabolism
  • Reproductive Biology and Fertility
  • Cancer-related Molecular Pathways
  • Cancer Mechanisms and Therapy

New Generation University College
2008-2024

Seoul National University
2015-2024

Seoul National University Hospital
2011-2024

Ulsan College
2023

Severance Hospital
2023

Keimyung University Dongsan Medical Center
2023

Keimyung University
2023

Samsung Medical Center
2023

Sungkyunkwan University
2023

University of Ulsan
2023

Purpose The aim of this study was to develop a preoperative risk prediction model for lymph node metastasis in patients with endometrial cancer and identify low-risk group before surgery. Patients Methods medical records 360 who underwent surgical staging were collected from four institutions retrospectively reviewed. By using serum CA-125 levels, biopsy data, magnetic resonance imaging (MRI) multivariate logistic created. whose predicted probability less than 4% defined as low risk....

10.1200/jco.2011.38.2416 article EN Journal of Clinical Oncology 2012-03-13

The purpose of this study was to evaluate the predictive value preoperative serum CA-125 levels in assessment disease extent and clinical outcome endometrial cancer.This retrospective evaluated 92 women with pathologically proven carcinoma scheduled for treatment that had between January 1999 February 2006. association a variety histopathologic factors evaluated. Statistical analysis performed using chi2/Fisher's exact test logistic regression. Survival studied Kaplan-Meier method Cox...

10.1080/00016340601022777 article EN Acta Obstetricia Et Gynecologica Scandinavica 2006-12-01

To estimate the effects of vaginal pH-balanced gel on symptoms and atrophy in breast cancer survivors treated with chemotherapy or endocrine therapy.This was a randomized, double-blind, placebo-controlled study. Breast who experienced menopause after therapy were voluntarily enrolled randomly administered topical placebo three times per week for 12 weeks. Vaginal dryness dyspareunia measured by visual analog scale, health index, pH. The endometrium ovary evaluated transvaginal...

10.1097/aog.0b013e3182118790 article EN Obstetrics and Gynecology 2011-03-23

To test an electrically conductive chip, incorporating a nanoroughened microfluidic platform for the capture of circulating tumor cells (CTCs), and assess its clinical merit in instances epithelial ovarian cancer (EOC).A total 54 patients with EOC recruited between August 2014 May 2015 were enrolled this prospective study. CTCs peripheral blood detected advance primary resection before initiating adjuvant chemotherapy recurrent disease. We identified as EpCAM-positive DAPI-positive,...

10.1016/j.ygyno.2017.02.042 article EN cc-by-nc-nd Gynecologic Oncology 2017-03-07

We compared the predictive and prognostic values of leukocyte differential counts, systemic inflammatory (SIR) markers cancer antigen 125 (CA-125) levels, identified most useful marker in patients with ovarian clear cell carcinoma (OCCC). The study included 109 OCCC who did not have any conditions except endometriosis, underwent primary debulking surgery between 1997 2012. Leukocyte counts (neutrophil, lymphocyte, monocyte, eosinophil, basophil, platelet), SIR including neutrophil to...

10.4143/crt.2014.324 article EN Cancer Research and Treatment 2015-03-06

To evaluate impact of germline BRCA mutational status on prognosis in patients with advanced ovarian cancer. A total 128 diagnosed FIGO stage III-IV high-grade serous cancer (HGSOC) between 2008 and 2017 underwent BRCA1/2 gene testing at the time or within two years from diagnosis were included this study. We compared patients' clinicopathological characteristics survival outcomes after primary treatment according to status. Treatment-related factors that might affect outcome also...

10.1186/s13048-019-0511-7 article EN cc-by Journal of Ovarian Research 2019-05-07

MRI for Pretreatment Lymph Node Staging in Uterine Cervical CancerHyuck Jae Choi1, Seung Hyup Kim2, San-Soo Seo1, Sokbom Kang1, Sun Lee1, Joo-Young Kim1, Young Hoon Jong Seok Hyun Chung1, Joo-Hyuk Lee1 and Sang-Yoon Park1Audio Available | Share

10.2214/ajr.05.0263 article EN American Journal of Roentgenology 2006-10-20

<i>Background:</i> The aim of this study was to compare the efficacy, safety and achievement target hemoglobin level (Hb ≥10 g/dl) in patients with preoperative anemia due menorrhagia who received intravenous iron sucrose compared oral protein succinylate for management. <i>Methods:</i> Seventy-six Hb levels <9.0 g/dl were scheduled undergo surgical treatment randomized receive either (based on calculated total deficit divided into 2 ampoule infusions intravenously...

10.1159/000210062 article EN Acta Haematologica 2009-01-01

We investigated the prognostic value of intratumoral [¹⁸F]fluorodeoxyglucose (FDG) uptake heterogeneity (IFH) derived from positron emission tomography/computed tomography (PET/CT) in patients with cervical cancer. Patients uterine cancer International Federation Obstetrics and Gynecology (FIGO) stage IB to IIA were imaged [¹⁸F]FDG PET/CT before radical surgery. parameters such as maximum average standardized values (SUV(max) SUV(avg)), metabolic tumor volume (MTV), total lesion glycolysis...

10.3802/jgo.2016.27.e15 article EN cc-by-nc Journal of Gynecologic Oncology 2015-12-21

Clinical practice guidelines for gynecologic cancers have been developed by academic society from several countries.Each guideline reflected their own insurance system and unique medical environment, based on the published evidence.The Korean Society of Gynecologic Oncology (KSGO) first edition cancer treatment in late 2006; second was released July 2010 as an evidence-based recommendation.The Guidelines Revision Committee established 2015 decided to develop third advanced format medicine,...

10.3802/jgo.2017.28.e22 article EN cc-by-nc Journal of Gynecologic Oncology 2017-01-01
Coming Soon ...